REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto de Nefrologia Pichincha Insnep CIA Ltda (Ecuador)

Main Activities: Offices of Physicians
Full name: Instituto de Nefrologia Pichincha Insnep CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Instituto de Nefrologia Pichincha Insnep CIA Ltda is a company based in Ecuador, with its head office in Quito. The company operates in the Offices of Physicians sector. The enterprise was incorporated on July 19, 1995. It currently has a total number of 38 (2021) employees. From the latest financial highlights, Instituto de Nefrologia Pichincha Insnep CIA Ltda reported a net sales revenue increase of 54.11% in 2022. Its total assets decreased by 7.61% over the same period. The enterprise’s net profit margin increased by 6.27% in 2022.

Headquarters
Veintimilla E-241, D Bldg.
Quito; Pichincha;

Contact Details: Purchase the Instituto de Nefrologia Pichincha Insnep CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Instituto de Nefrologia Pichincha Insnep CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Instituto de Nefrologia Pichincha Insnep CIA Ltda report to view the information.
Registered Capital:
Purchase the Instituto de Nefrologia Pichincha Insnep CIA Ltda report to view the information.
Incorporation Date:
July 19, 1995
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Instituto de Nefrologia Pichincha Insnep CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
54.11%
Total operating revenue
53.3%
Operating profit (EBIT)
454.96%
EBITDA
214.14%
Net Profit (Loss) for the Period
513.76%
Total assets
-7.61%
Total equity
17.83%
Operating Profit Margin (ROS)
13.09%
Net Profit Margin
6.27%
Return on Equity (ROE)
12.38%
Quick Ratio
0.08%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?